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Abstract The goal of this study is to validate a new,
continuous, noninvasive stroke volume (SV) method,
known as transbrachial electrical bioimpedance velocime-
try (TBEV). TBEV SV was compared to SV obtained by
cardiac magnetic resonance imaging (cMRI) in normal
humans devoid of clinically apparent heart disease. Thirty-
two (32) volunteers were enrolled in the study. Each sub-
ject was evaluated by echocardiography to assure that no
aortic or mitral valve disease was present. Subsequently,
each subject underwent electrical interrogation of the bra-
chial artery by means of a high frequency, low amplitude
alternating current. A first TBEV SV estimate was ob-
tained. Immediately after the initial TBEV study, subjects
underwent cMRI, using steady-state precession imaging to
obtain a volumetric estimate of SV. Following cMRI, the
TBEV SV study was repeated. Comparing the cMRI-
derived SV to that of TBEV, the two TBEV estimates were
averaged and compared to the cMRI standard. CO was
computed as the product of SV and heart rate. Statistical
methods consisted of Bland–Altman and linear regression
analysis. TBEV SV and CO estimates were obtained in 30
of the 32 subjects enrolled. Bland–Altman analysis of pre-
and post-cMRI TBEV SV showed a mean bias of 2.87 %
(2.05 mL), precision of 13.59 % (11.99 mL) and 95 %
limits of agreement (LOA) of ?29.51 % (25.55 mL) and
-23.77 % (-21.45 mL). Regression analysis for pre- and
post-cMRI TBEV SV values yielded y = 0.76x ? 25.1
and r2 = 0.71 (r = 0.84). Bland–Altman analysis com-
paring cMRI SV with averaged TBEV SV showed a mean
bias of -1.56 % (-1.53 mL), precision of 13.47 %
(12.84 mL), 95 % LOA of ?24.85 % (?23.64 mL) and
-27.97 % (-26.7 mL) and percent error = 26.2 %. For
correlation analysis, the regression equation was y =
0.82x ? 19.1 and correlation coefficient r2 = 0.61
(r = 0.78). Bland–Altman analysis of averaged pre- and post-
cMRI TBEV CO versus cMRI CO yielded a mean bias of
5.01 % (0.32 L min-1), precision of 12.85 % (0.77 L min-1),
95 % LOA of ?30.20 % (?0.1.83 L min-1) and -20.7 %
(-1.19 L min-1) and percent error = 24.8 %. Regression
analysis yielded y = 0.92x ? 0.78, correlation coefficient
r2 = 0.74 (r = 0.86). TBEV is a novel, noninvasive method,
which provides satisfactory estimates of SV and CO in normal
humans.
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1 Introduction
Ejection of SV is the primary mechanical function of the
heart and, in response to metabolic oxygen requirements
SV is modulated by contractility, loading conditions, and
heart rate to produce the requisite cardiac output (CO). CO
is the ultimate expression of cardiovascular performance
and, because it is the cornerstone of oxygen transport goal-
oriented therapy, its assessment and optimization in
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critically-ill humans is of paramount importance [1].
Thermodilution cardiac output (TDCO) is currently the
gold standard method for CO determination in the critically
ill [2, 3]. However, with the virtual demise of the pul-
monary artery catheter as a diagnostic tool for estimating
left ventricular preload [4, 5], its justification and indica-
tions for TDCO determination are becoming slimmer and
more stringent [6, 7]. Because of its invasiveness and po-
tential complications, a search for minimally invasive or
noninvasive alternatives for TDCO is ongoing [8–10].
What is readily apparent from review of the literature is
the paucity of accurate, simple, technician-independent,
‘‘hands-off’’, continuous, noninvasive CO methods, which
do not require external calibration [3, 8–10]. Transthoracic
electrical bioimpedance cardiography, otherwise known as
impedance cardiography (ICG), is a technology that fulfills
all the requirements for an ideal CO method, except for its
lack of consistent accuracy [3, 8–11]. Because of the
generally poor performance of the transthoracic technique
in sick humans [11, 12], and especially those with excess
intrathoracic extravascular lung water [13, 14], the tech-
nology has been deemed of marginal usefulness in the care
of the critically ill [11].
This study in normal humans concerns the validation of a
new noninvasive, velocimetric-based, pulsatile SV technique,
known as transbrachial electrical bioimpedance velocimetry
(TBEV) [15]. As compared to ICG implemented transtho-
racically, TBEV is, in theory and method, an ICG equivalent,
but operationally signal acquisition is obtained from the upper
arm. For this validation study, TBEVSV is compared with that
obtained from cardiac magnetic resonance imaging (cMRI),
which is considered the absolute ‘‘gold-standard’’ for deter-
mination of ventricular volumes [16, 17].
2 Methods
2.1 Study population
Thirty-two (32) volunteer adult subjects were recruited for the
study. By history, physical examination, electrocardiography,
echocardiography, and magnetic resonance imaging, the
subjects showed no demonstrable evidence of heart disease.
Since cMRI is considered the absolute gold standard for
measurement of ventricular volumes [16, 17], SV obtained
from that technique was compared to SV determined by
TBEV [15]. In order to obtain a wide spectrum of SV and CO,
subjects were recruitedwith a broad range of heights, weights,
and body mass indices (BMI). Body surface area (BSA) for
each subject was calculated using theMosteller equation [18]
(Table 1). This study was approved by the Institutional Re-
view Board of the University of California, as well as Aspire
Institutional Review Board, San Diego, and all subjects pro-
vided written and oral informed consent.
2.2 Echocardiography protocol
All subjects underwent echocardiography, including color,
pulsed, and continuous wave Doppler. Studies were per-
formed using a commercially available echograph (iE33,
Philips Medical, Andover, MA) with a broadband
2.0–3.5 MHz phased-array transducer to assess the pres-
ence of mitral and/or aortic valve disease. This was to
ensure that all participants had structurally normal hearts.
Subjects were positioned in the left lateral decubitus po-
sition and standard images were obtained from the
parasternal and apical windows in accordance with current
guidelines [19]. Data were acquired and stored in digital
format, then analyzed offline using a separate workstation.
2.3 MRI protocol
Subjects were scanned on a Signa 1.5T HDx scanner (GE
Healthcare, Milwaukee, WI). After localizing images were
obtained, a short axis stack of images through the entire left
ventricle was acquired during end-expiration, using steady-s-
tate free precession (SSFP) imaging with a slice thickness of
8 mm, spacing of 2 mm, in-plane grid of 224 9 224, and ac-
celeration factor of 1.5. The number of views per segment was
adjusted as needed to yield a temporal resolution of 50 ms or
less, and the field of view was adjusted as needed, based upon
each subject’s habitus. HR was recorded for each acquisition
and the averageHRduring imagingwas computed. Each cMRI
scan was completed in approximately 1 (one) hour.
Table 1 Subject characteristics and cMRI measurements: all data are presented as the mean ± standard deviation (SD)
Males (%) 24 (75 %) End diastolic volume 154 ± 26.9 mL
Age 41.5 ± 12.5 years End systolic volume 58.1 ± 11.9 mL
Weight 83.3 ± 20.2 kg Stroke volume 96.1 ± 18.6 mL
Body mass index 26 ± 4.4 kg m-2 Ejection fraction 62.2 ± 4.6 %
Body surface area 2.02 ± 0.30 m2 Cardiac output 6.08 ± 1.3 L min-1
Heart rate 63.3 ± 7.6 beats min-1 Cardiac index 3.00 ± 0.41 L min-1 m-2
See text (Sect. 2.4) for calculation of SV and ejection fraction
790 J Clin Monit Comput (2015) 29:789–800
123
2.4 cMRI image analysis
MRI images were analyzed offline, using an Advantage
Workstation with ReportCard 4.0 (GE Healthcare, Mil-
waukee, WI). End-systolic and end-diastolic frames were
manually identified by visual inspection of the largest and
smallest volume. Then, for each slice, the endocardium was
manually traced at these two time points, including the
papillary muscles with the contours, and left ventricular
volume was subsequently calculated using the modified
Simpson’s method [16]. SV was determined as the differ-
ence between the end-diastolic and end-systolic volumes.
CO was then calculated as the product of measured SV and
the average recorded HR. Stroke index (SI) and cardiac
index (CI) were calculated as the SV and CO divided by
BSA.
2.5 Transbrachial electrical (bioimpedance)
velocimetry (TBEV)
2.5.1 TBEV device
The TBEV system is a wearable, battery-powered, four-
lead impedance cardiograph. It is worn on the upper arm
and is held in place only by custom adhesive electrode
patches (Vermed, Inc, Bellows Falls, VT, USA) (Fig. 1a).
The system consists of two electrical housings connected
by an electric cable: (1) a proximal assembly that is at-
tached to a dual-element electrode, which is placed below
the clavicle, proximal to the humeral head and axilla; and
(2) a dual-element distal assembly which is attached to the
anteromedial surface of the upper arm, proximal to the
antecubital fossa (Fig. 1a, b). Using this electrode ar-
rangement for interrogation of the brachial artery, an al-
ternating current (ac, I, A) field is applied along and within
the long axis of the upper arm. As a result of passing ac
through an electrical impedance Z (ohm, X) (i.e. resistance
to ac), a potential difference (voltage, U) within the current
field is obtained. This is an expression of Ohm’s Law ap-
plied to biological tissues (i.e. IZ = U). The proximal
assembly houses the upper voltage sensor and current
driver, and the distal assembly houses the electronic circuit
board into which the lower voltage sensor and current
driver are integrated [15]. Figure 1b is a photograph of a
human volunteer wearing the TBEV montage.
The TBEV analog circuit emits a constant magnitude,
small amplitude 70 kHz, 4 mA RMS ac source, driving the
signal through a segment of the upper arm through the
current driver electrodes (Fig. 1a). The 70 kHz carrier
signals from each voltage sensor first pass through identical
filters (25 kHz low pass and 20 kHz high pass) and am-
plification stages. The signals are then differentially am-
plified and passed to an amplitude demodulation circuit.
The high and low frequency components of the total
transthoracic impedance (Z(t)) are then separated into two
major components; (1) DZ, further comprising (a), a si-
nusoidal respiratory component, which is filtered out, and
(b), a superimposed pulsatile time-variable ac cardiody-
namic component (DZ(t)), and (2) Z0, a quasi-static
transbrachial base impedance, respectively. Further signal
processing of DZ(t) entails finding the peak value of the
first time-derivative of dZ/dt (i.e. dZ/dtmax, X s
-2), and
systolic flow time (TSF, s) from fiducial landmarks on the
dZ/dt waveform [15, 20] (Fig. 2a, b). Finally, to obtain
ohmic mean velocity, the quotient of dZ/dtmax and Z0 un-
dergo square root transformation. To obtain SV, a
volumetric constant (VC, mL) is calculated from total body
weight (W, kg), whereupon the variables are placed into
the SV equation (vide infra).
The TBEV analog electronics were identical across all
subjects. The waveforms for subjects 1 through 13 were
digitized in real-time using a BIOPAC UIM100C system
(BIOPAC, Goleta, CA, USA) and then stored on a laptop
PC for later analysis. All waveforms were sampled at
16-bit resolution and 500 Hz. In addition, A BIOPAC
Fig. 1 a A pictorial circuit diagram from which SV and CO are
obtained. Shown are the upper and lower housings for the electrode
patches on the arm. AC is injected via the outer electrodes and voltage
electrodes are shown as the inner electrodes. Voltage is demodulated,
amplified and filtered to obtain Z0 and DZ(t), which then undergo
analog to digital (A to D) conversion. Electronic differentiation of
DZ(t) yields dZ/dt. dZ/dtmax/Z0 undergoes square root transformation.
TSF (systolic flow time) is multiplied by the volume conductor (VC)
and ([dZ/dtmax/Z0])
0.5 to obtain stroke volume (SV). SV is multiplied
by heart rate (HR) to obtain cardiac output (CO). Details found in
text. b Photograph of volunteer with ECG patch electrodes on upper
chest, TBEV electrode housing on the upper brachium, and wiring to
an electrode housing just proximal to the antecubital fossa. The
impedance signals are relayed to a signal processor shown on the
wrist. Also shown is a pulse oximeter on thumb
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ECG100C module was used to collect a single ECG lead II
waveform for determining HR and gating of dZ/dt. Sub-
jects 14 though 32 were digitized using an integrated
digital sub-system on the TBEV circuit board (Sotera
Wireless, San Diego, CA, 92121, USA). With regard to the
two prototype impedance platforms, they were op-
erationally identical for signal acquisition and data
processing.
2.5.2 Assumptions of the method [15, 20, 21]
It is assumed that;
1. Schematically, the brachium can be considered a
thin-walled cylinder, encasing an aggregate of
adynamic tissues of high impedance, which, in turn,
encircle a single dynamic blood-filled vascular
conduit of low impedance.
2. When an ac field is applied longitudinally over a
segment of the brachium, the brachium can be
considered, bio-electrically, a parallel conduction
curcuit, connecting (1) a poorly conductive static
tissue impedance, Zt, (2) a highly conductive blood
resistance (Rb, Zb), and (3) the smallest volume, but
highest conductivity impedance, reflecting the quasi-
static interstitial tissue water, (Zw), varying with tissue
hydration. The parallel (k) reciprocal sum, Zt-1 ? -
Zb
-1 ? Zw
-1, constitutes the quasi-static base impe-
dance, Z0. When the static and quasi-static tissue
impedances are added in parallel with the time-
dependent, dynamic pulsatile component of the blood
resistance (DRb(t) : DZb(t)), the total transbrachial
impedance, Z(t) results. As per Ohm’s Law (vide
supra); when an ac field is uniformly applied longitu-
dinally across both the static and dynamic impedances,
a potential difference between the current injecting
electrodes produces the parallel connection of a static
and dynamic voltage; U0
-1 and DUb(t)
-1, respectively.
In concise bio-electric mathematical language,
IðtÞ  Ztk kZb Zwkð Þ DZbðtÞk½  ¼ U0kDUbðtÞ ð1Þ
A schematic electronic circuit diagram reflecting
Eq. 1 is given as follows (Fig. 3).
3. The brachial artery is poorly compliant and me-
chanically resembles a rigid muscular tube, render-
ing volume changes trivial. Thus,
4. All cardiogenically-induced impedance changes
(DZb(t)) are due solely to blood velocity-induced
resistivity changes (Dqb(t), X cm s
-1)
Fig. 2 a In the upper tracing is shown a dZ/dt waveform from the
thorax. In the lower tracing is shown a dZ/dt tracing from the
brachium. Note that for the transthoracic waveform, the end of
ejection (flow) is the nadir after the first zero crossing after point C,
dZ/dtmax. In the lower tracing is shown a dZ/dt waveform obtained
from the brachium. Note that the end of flow is the second zero
crossing after point C, dZ/dtmax. The waveforms were obtained
simultaneously, but, because of the transmission delay, they were
aligned synchronously in time to illustrate the same TSF. b The
transbrachial impedance pulse variation DZ (upper tracing) and its
differentiated first time-derivative dZ/dt (lower tracing). In both
tracings the onset of flow is marked as point B, the maximum forward
slope of DZ and peak first time-derivative dZ/dtmax as point C, and
termination of flow as point X [20]. The temporal interval from B to
X is systolic flow time TSF
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5. The velocity-induced change in blood resistivity is
due to the changing orientation of the bi-concave,
disc-shaped erythrocytes from random orientation in
end-diastole (state of lowest conductivity) to parallel
orientation along their long axis of symmetry (state
of highest conductivity) in the rapid ejection phase
of systole
6. Transbrachial DZb(t) (X s
-1) is an ohmic analog of
brachial artery blood velocity (cm s-1), which
implies that its peak first time-derivative, dZ/dtmax
(X s-2), is an acceleration analog
7. Transbrachial dZ/dtmax (X s
-2) peaks precisely with
brachial artery peak blood acceleration (cm s-2)
8. Peak brachial artery acceleration (cm s-2) is directly
proportional to the magnitude and change of mag-
nitude of peak aortic blood acceleration (cm s-2)
9. Peak transthoracic dZ/dt (dZ/dtmax) is directly pro-
portional to the magnitude and change in magnitude
of peak aortic blood acceleration
10. Transbrachial dZ/dtmax is directly proportional to the
magnitude and change in magnitude of transthoracic
dZ/dtmax and thus,
11. Transbrachial dZ/dtmax is directly proportional to the
magnitude and changes in magnitude of peak aortic
blood acceleration.
12. To obtain dimensionless ohmic mean velocity (s-1),
square root transformation of dZ/dtmaz/Z0 is
necessary
13. A constant ratio of 2:1 exists between the magni-
tudes of transthoracic ohmic mean velocity and
transbrachial ohmic mean velocity, respectively.
Thus, reciprocally,
14. A constant ratio of 1:2 exists between the magni-
tudes of the transthoracic and transbrachial VC,
respectively
15. The magnitude of the transthoracic constant of
proportionality, otherwise known as the volume
conductor (VC, mL) is equivalent to the global
end-diastolic volume (GEDV, mL)
2.5.3 TBEV data collection protocol
Two 5-min sessions of TBEV waveforms were collected.
The first was collected immediately prior to the cMRI, and
the second immediately following the cMRI. The subjects
remained supine from the start of the first measurement,
through the cMRI, and until the end of the second TBEV
measurement. The subjects were instructed to remain silent
and still for the duration of the measurements.
2.5.4 TBEV signal processing
First, a 30 s interval out of each 5 min period was selected
for analysis. By default, this period was 150–180 s, but if
any significant artifact was present upon operator inspec-
tion, then a different 30-s period was selected manually. To
find a mean value over the relevant time interval, signal
averaging was implemented. This was the only manual
intervention in the analysis. TBEV SV was then calculated
according to the equation of Bernstein et al. [15].






• VC = volume conductor (mL) = 32 9 W1.02, where
W = total body weight (kg)
• dZ/dtmax = peak time rate of change of the trans-
brachial impedance pulse variation (X s-2)
• Z0 = quasi-static transbrachial base impedance (X)







= ohmic mean velocity (s-1)
Fig. 3 The transbrachial impedance (Z(t)) comprises four elements.
The three static elements include the impedance path through the
tissue (Zt), the blood (Zb), and the interstitial water (Zw). The parallel
connection of these static impedances constitutes the transbrachial
base impedance, Z0. The parallel connection between Z0 and the
pulsatile component, DZb(t), constitutes the total impedance of the
brachium (Z(t)). Shown is the current input (I(t)) and time variable
voltage output (U(t))
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Rationale for a mass-based VC, the square root trans-
formation, and the unit assignment of X s-2 for dZ/dtmax
are discussed extensively elsewhere [15, 20, 21].
2.5.5 Statistical analysis
For each group of subjects, to assess reproducibility and ac-
curacy, we employed Bland–Altman method and calculated
mean bias, standard deviations (SD), precision, limits of
agreement (LOA), and percent error for absolute values of the
continuous parameters studied [22]. Pearson’s correlation co-
efficient (r2) was calculated and used to assess the closeness of
association between continuous variables. For statistical ana-
lysis we used R version 3.0.0 (2013-04-03), Copyright
(C) 2013, The R Foundation for Statistical Computing.
3 Results
3.1 Demographics and echocardiography
The study population demographics are summarized in
Table 1. There were 24 males, the mean age was 41.5 ±
12.5 years, and the mean body mass index (BMI) was
26 ± 4.4 kg m-2 and ranged from 19 to 35 kg m-2. All
subjects were in normal sinus rhythm. Upon Doppler
echocardiographic interrogation, all subjects had trace or no
mitral regurgitation. One subject had mild aortic regurgita-
tion; all other subjects had trace or no aortic regurgitation.
3.2 cMRI
High quality cMRI images were obtained in all subjects
(n = 32) and displayed well-defined endocardial borders
that allowed calculation of left ventricular (LV) SV and CO.
Values for these and other cMRI parameters are listed in
Table 1. The average ejection fraction was 62.2 ± 4.6 %,
and the average CO was 6.08 ± 1.3 L min-1, with a mean
cardiac index of 3.00 ± 0.41 L min-1 m-2.
3.3 TBEV
The TBEV units functioned as intended, with high quality
waveform and digital data obtained in all but three subjects.
In two subjects, who were evaluated the same day, data ac-
quisition equipment malfunction occurred, and hence no
useable TBEV data was obtained. In a third subject, the pre-
MRI TBEV data was accidentally over-written due to op-
erator error and therefore was unavailable. Hence, full data-
sets were obtained in 29 subjects, and for a 30th subject, only
the post-MRI TBEV data was obtained. In a fourth subject,
the disparity between pre- and post-cMRI SV was 33 mL
(88.73–55.78 mL), which translates to Bland–Altman
percent difference of 45.7 %. The corresponding cMRI SV
was 102.2 mL. This disparity was probably due to a spurious
value of Z0 for the post TBEV measurement. Pre-TBEV Z0
was 60 versus 100 X for the post MRI Z0. This is impossible,
because there was no change in brachial tissue extra-cellular
water over the cMRI interval. The disparity, no doubt, was
due to a defective electrode or faulty adhesion of the elec-
trode-to-skin interface. Despite this obvious outlier, the
paired estimates were included in statistical analysis. Raw
TBEV input and output variables are shown in Table 2. The
results demonstrate that, for pre- and post-cMRI, the mean
values for TSF, Z0, SV, HR and CO are virtually unchanged
for males and females. The largest mean difference from pre-
to post-cMRI occurred in dZ/dtmax for both males (9 %) and
females (6 %). Also of interest, the mean value of the mag-
nitude of the male VC is approximately 50 % larger than the
female counterpart. If the mean value of the magnitude of
ohmic mean velocity is calculated from the data (see Eq. 2),
female values are about 18 % higher than the male cohort. In
conjunction with a 3 % longer TFS in females, the difference
between males and females renders SV in males ap-
proximately 25 to 30 % higher. A total of 30 subjects were
used in statistical analysis (n = 30).
3.4 Bland–Altman: mean bias, precision, and limits
of agreement (LOA)
Mean bias, precision, mean bias ± 1.96 9 SD (LOA), and
percent error for TBEV SV versus cMRI SV and TBEV CO
versus cMRI CO are shown in Table 3. Of note in Table 3
are the small biases, similar levels of precision, and LOA for
the three paired comparisons. Percent error for TBEV SV
versus cMRI SV and TBEV CO versus cMRI CO are vir-
tually identical, being 26.2 and 24.8 %, respectively. Since
cMRI SV is essentially without precision error, the disparity
in measurements of SV and CO between the methods can be
attributed almost entirely to the precision errors of TBEV.
Bland–Altman methodology was used to assess comparisons
of TBEV pre- versus post-cMRI SV, averaged TBEV SV
versus cMRI SV and averaged TBEV CO versus cMRI CO.
This analysis also assumes that true SV remained unchanged
over the cMRI interval. Table 3 and Fig. 4a show results of
Bland–Altman analysis for TBEV CO versus cMRI CO.
3.5 Linear regression analysis
The regression coefficients, y-intercepts, and correlation
coefficients for three paired comparisons are presented in
Table 4. It is interesting to note that, for TBEV SV versus
cMRI SV is the lowest of the three comparisons with a
regression coefficient of 0.82 and correlation coefficient of
r2 = 0.61 (r = 0.78). The regression coefficient in Fig. 4b is
a scatterplot of TBEV CO versus cMRI CO, showing a
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correlation coefficient r2 = 0.74 (r = 0.86), a regression
coefficient close to unity (i.e. 0.92), and a y-intercept less
than 1 (one) L min-1 (i.e. 0.78 L min-1). This suggests
little systematic bias of CO between the methods. Due to the
absolute precision of cMRI SV, the scatter around the re-
gression line represents random errors of the TBEV method.
4 Discussion
4.1 Recent studies and historical aspects
Results obtained in this study are similar to our previous
study in normals, comparing TBEV SV to Doppler/echo-
derived SV [15, 20]. By Bland–Altman method, the mean
bias was -4.0 % (2.5 mL), precision of 14.7 % (11.9 mL),
and limits of agreement of ?33.4 and -25.4 %. Contrary
to the sequence of method comparisons in this study, which
were spaced-apart temporally, in our prior study Doppler/
echo and TBEV SV measurements were obtained
simultaneously.
Transbrachial SV determination is not without historical
precedent. It is interesting to note that, in Nyboer’s seminal
article in 1950, he used a 4 band-electrode montage on the
forearm to obtain plethysmographic (volumetric) impe-
dance measurements [23]. That article also presented the
original equations that evolved into those used in
transthoracic ICG [21]. Using a similar electrode array to
ours, a more recent study, assessing cardiogenically-
Table 2 TBEV equation input
and output variables:
VC = volume conductor (mL),
TSF = systolic flow time (ms),
dZ/dtmax = peak time rate of
change of the transbrachial
impedance pulse variation
(X s-2, ohm s-2),
Z0 = transbrachial quasi-static
base impedance (X),
SV = stroke volume (mL),
HR = heart rate (beats min-1),
CO = cardiac output (L min-1)
Pre-MRI session Males (n = 21) Females (n = 8)
Mean ± SD Range Mean ± SD Range
Vc (mL) 2929 ± 458 2144–4000 1914 ± 541 1571–3286
TSF (ms) 321 ± 19.2 276–356 328.8 ± 25.3 296–388
dZ/dtmax (X s
-2) 0.97 ± 0.39 0.47–1.92 1.60 ± 0.41 1.03–2.46
Z0 (X) 74.3 ± 11 49–96 86.6 ± 15.4 64.9–113.8
SV (mL) 104.1 ± 16.3 75.9–143.8 83.8 ± 19.9 70.7–135.3
HR (BPM) 67 ± 8 53–86 61 ± 7 55–71
CO (L min-1) 6.9 ± 1.1 5.1–9.4 5.2 ± 1.7 3.9–9.7
Post-MRI session Males (n = 22) Females (n = 8)
Mean ± SD Range Mean ± SD Range
Vc (mL) 2935 ± 448 2144–4000 1914 ± 541 1571–3286
TSF (ms) 318 ± 22.7 278–372 328 ± 32.3 288–384
dZ/dtmax (X s
-2) 0.89 ± 0.29 0.42–1.67 1.51 ± 0.52 0.86–2.65
Z0 (X) 72.1 ± 14.2 41.8–100.0 90.0 ± 20.7 51.4–117.8
SV (mL) 102.5 ± 18.4 55.8–138.2 80.0 ± 20.4 54.4–128.3
HR (BPM) 67 ± 8 57–86 61 ± 7 50–72
CO (L min-1) 6.8 ± 1.3 3.4–8.7 5.0 ± 1.7 3.6–8.9
Table 3 Bland–Altman
analysis: the aggregate mean
value of the paired values are
presented as mean bias,
precision, and ±95 % limits of
agreement (LOA), which are
presented as percent (%) and
mL
Percent error is computed for
absolute values of SV and CO.
For cardiac output (CO) mean
bias, precision, and ±95 %
LOA are presented as (%) and
L min-1. Note that the mean
biases are small and the SD,
precision and limits of






95 % Limits of agreement
Upper (%) Lower (%) % Error
TBEV SV-1 versus TBEV SV-2 2.87 13.59 ?29.51 -23.77 –
TBEV SV versus cMRI SV -1.56 13.47 ?24.85 -27.97 –
TBEV CO versus cMRI CO 5.01 12.85 ?30.20 -20.17 –
Mean
bias (mL)
Precision (mL) 95 % Limits of agreement
Upper (mL) Lower (mL) % Error
TBEV SV-1 versus TBEV SV-2 2.05 11.99 ?25.55 -21.45 –









TBEV CO versus cMRI CO 0.32 0.77 ?1.83 -1.19 24.8
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induced bioimpedance changes of the forearm, has shown
close correspondence between SV changes and percent
changes obtained from the aortic root and the changes and
percent changes in both the maximum amplitude of the
impedance pulse variation DZmax (r = 0.86 and r = 0.84,
respectively) and the area beneath the DZ waveform en-
velope (r = 0.78 and r = 0.78, respectively) [24].
4.2 Strength and advantages of TBEV
First, in contrast to the transthoracic approach, there are
virtually no potentially confounding or competing vessel
resistivities or volume changes in the upper arm. The sole
vessel of any magnitude is the brachial artery, which is
probably the only major source providing a waveform for
signal processing. Unlike transthoracic dZ/dt, which has
multiple signal sources and both a volumetric and blood
velocity-induced resistivity component [25], the brachial
artery is sufficiently stiff to yield a signal whose origin is
purely reflective of axial blood flow [15]. Secondly, unlike
the transthoracic method, which is highly susceptible to
excess extravascular lung water [13, 14], brachial mea-
surements are taken distant from the lung and apart from
the bony thorax. As a consequence of the upper arm being
detached from the thorax, the wide respiratory-induced
oscillations of baseline impedance (Z0), seen in the
transthoracic approach, are much attenuated in the upper
arm. As concerns signal processing, this improves detec-
tion of baseline impedance Z0, leading to fewer
morphologic distortions of DZb(t), thus resulting in less
need for adaptive filtering.
4.3 Limitations and errors of the method and study
design
The results from this study suggest that the theory and
equations are, at least in the first approximation, correct.
However, it must be remembered that this study was con-
ducted with healthy volunteers who were apparently free of
heart disease. Potential mechanical limitations of the
method entail atherosclerotic obstructive disease of the
subclavian and axillo-brachial circulations, namely sub-
clavian and axillo-brachial stenosis [26]. Stenosis induces
high velocity jets, blood turbulence, and disturbed laminar
flow, precluding accurate SV determination [27]. Hemo-
dynamically, abnormal ejection patterns can potentially
cause distortion of the brachial artery waveform envelope,
thereby preventing accurate signal processing [27, 28].
Clearly, random errors in measurement of dZ/dtmax, Z0, and
systolic flow time (TSF) can degrade the accuracy of the
method. Operationally, defective electrodes will yield in-
valid results.
Two serious design flaws in our study protocol entailed;
(1) the non-simultaneity of the TBEV and cMRI mea-
surements and (2) the lack of a gold-standard continuous
method by which to assess TBEV’s accuracy and tracking/
trending capability over a wide range of hemodynamic
perturbations. In this regard, we were unable to completely
Fig. 4 a Bland–Altman
analysis: average TBEV CO
versus cMRI CO See Table 3
for mean bias precision, ±LOA,
and percent error. b Correlation
analysis for TBEV CO versus
cMRI CO: the slope (0.92) and
y-intercept (0.78) suggest little
systematic bias. See Table 4
Table 4 Linear regression analysis for TBEV SV-1 (pre-) versus TBEV SV-2 (post), Average TBEV SV versus cMRI SV, and average TBEV
CO versus cMRI CO
TBEV and cMRI comparisons Regression equation
(y = mx ? b)
Correlation coefficient
(r2, r)
TBEV SV-1 versus TBEV SV-2 y = 0.76x ? 25.1 r2 = 0.71, r = 0.84
Average TBEV SV versus cMRI SV y = 0.82x ? 19.1 r2 = 0.61, r = 0.78
Average TBEV CO versus cMRI CO y = 0.92x ? 0.78 r2 = 0.74, r = 0.86
Note that for CO the slope is nearly 1 and the y-intercept\1 L min-1
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verify assumptions 8 through 11 (Sect. 2.5.2). Concerning
lack of simultaneity of the TBEV measurements, the fol-
lowing is relevant; since all metallic objects of ferric origin
are contraindicated while undergoing cMRI, the TBEV
cables, electrodes, and wrist-worn device were obligatorily
disconnected and then reconnected. It was originally as-
sumed that TBEV SV would not change during the cMRI
interval, and if it did, only minimally. Judging by the
precision and LOA of the two TBEV comparison mea-
surements (Table 3), it is difficult to determine whether SV
actually changed, or was simply a function of the impre-
cision of the method. Since the two TBEV measurements
were separated by about an hour, a combination of preci-
sion error and actual change in SV probably occurred. It is
thus speculated that, had the comparison between simul-
taneous measurements of TBEV SV versus cMRI SV been
technically possible, the precision and accuracy may have
been appreciably better. Again, regarding the non-simul-
taneity of TBEV versus cMRI measurements, it was our
objective to compare precision and accuracy with an ab-
solute measurement of SV. Clearly, it was an erroneous
assumption that the two TBEV measurements would re-
main constant over the cMRI interval, or that the average
of the two measurements would represent the time-aver-
aged cMRI SV over the scanning period.
As concerns clinical efficacy, it is not known how
changes in loading conditions or administration of va-
sodilators, vasoconstrictors or inotropic medications will
affect the accuracy of the TBEV measurement. On this
very issue, Chemla et al. [29, 31] found that, unlike peak
velocity, brachial artery peak acceleration was unaffected
by downstream vasoactivity and only by positive or
negative b1 inotropic and chronotropic medications di-
rectly affecting the adrenoceptors of the myocardium. This
suggests that ohmic peak brachial artery acceleration (i.e.
dZ/dtmax) may respond similarly.
Other limitations of the study include a cohort mainly of
males (22/8) and the inability to obtain TBEV waveforms
in the presence of arm or body motion or complex dys-
rhythmias, including atrial fibrillation. While the imple-
mentation of two prototype impedance platforms might be
perceived as a limitation, they were operationally identical
for signal acquisition and data processing.
4.4 Assumptions and inherent errors of the method
4.4.1 A constant ratio of 2:1 exists between the magnitudes
of transthoracic and transbrachial ohmic mean
velocity
A basic assumption of the method assumes that using
transthoracic dZ/dtmax and the parent equation of Eq. 1
[30], results in valid approximations of SV. As described in
prior publications, the accuracy and precision of TBEV SV
depends upon a monotonically fixed ratio between the
magnitudes and changes in magnitude of peak aortic and
peak brachial artery blood acceleration (dv/dtmax, cm s
-2;
dQ/dtmax, mL s
-2) [15, 20, 31]. Since transthoracic and
transbrachial dZ/dtmax are considered ohmic analogs of
peak aortic and peak brachial artery blood acceleration,
respectively [15, 31], it was hypothesized that SV could be
obtained from the brachial artery using the skeleton of
Eq. 1 (vide supra) [30]. Pursuant to that hypothesis, it was
found that the ratio of transthoracic to transbrachial ohmic
mean velocity ([dZ/dtmaxZ0-1]0.5, s-1) was approximately 2
to 1 (i.e. 2:1) [15, 20]. Comparing the latter to the former,
we found a mean bias of -46.4 % (*50 %), a transtho-
racic to transbrachial mean ratio of 2.16:1, and percent
deviation from 2:1 of 8 %. In 36 of the 38 study subjects
(94.7 %), paired data points were equal to or less than
15 % from the mean [20]. Thus, at the operational level,
and as an inherent pre-requisite assumption of the method,
the direct proportionality and a constant 2:1 ratio between
transthoracic and transbrachial ohmic mean velocity may
not exist in an unknown patient population. These ratios
may even change in the same individual over time and may
account for some portion of the precision error between
pre- and post-cMRI TBEV SV measurements (Table 3).
This can lead to an unpredictable degree of uncontrollable
under or overestimation of transbrachial ohmic mean ve-
locity, and thus SV. Thus, assumption 13 (Sect. 2.5.2) is
only an approximation.
4.4.2 An allometric relationship between body weight
and GEDV is a constant
Since the ratio of transthoracic to transbrachial ohmic mean
velocity is approximately 2:1, and in an abstraction of the
equation of continuity for conservation of mass flow, the
ratio of the magnitude of transthoracic to the transbrachial
VC was set empirically and reciprocally at 1:2.
Theoretically, the physical embodiment of the transtho-
racic VC was estimated to approximate the GEDV. Thus,
the allometric relationship of body weight to GEDV was
empirically approximated as 16W1.02 (*17 mL kg-1)
[30].1 For allometrics, the relationship of body weight to
GEDV is given as aMb, where ‘‘a’’ is a constant of pro-
portionality, M is patient body mass (kg), and ‘‘b’’ is an
exponential constant describing linearity or non-linearity
[32]. The exponential constant, 1.02, implies a linear re-
lationship between body weight and GEDV. Conversion of
body weight directly to blood volume is valid, because the
density of blood (q, g mL-1) is 1.05–1.06. When
1 In earlier publications [15, 23, 31], the VC was erroneously thought
to approximate the ITBV.
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empirically derived GEDV is multiplied by a mean value
of 1.25, the generally accepted mean correction factor for
conversion to intrathoracic blood volume (ITBV) (range
1.21–1.45) [33], 21.25 mL kg-1 is the result. This em-
pirically-derived calculated value was verified experimen-
tally by Moller et al. [34] as the indexed mean ITBV for
patients without cirrhosis. Further interpretation of their
data for these patients yielded a pooled SD of ap-
proximately ±4.7 mL kg-1, corresponding to ±22 %. By
mathematical coupling, this percent error is fully trans-
ferrable to the GEDV. Corroborating the aforementioned
studies, data provided by Metzelder et al. [35] show that,
for a mean control ITBV of 1638 mL and a mean weight
for patients of 74 kg, the mean calculated indexed ITBV
was 22.14 mL kg-1. When this value is divided by 1.25 to
obtain GEDV, the result is 17.7 mL kg-1. This value is
4.7 % greater than using the transthoracic coefficient and
exponent, 161.02 (i.e. 16.9 mL kg-1). While the measured
mean indexed values for the ITBV are well described by
the allometric expression, 16W1.02 multiplied by 1.25 [33],
the rather substantial standard deviations, especially those
reported by Moller et al. [34], contribute to the error of the
fixed-value transbrachial coefficient and exponent, 321.02
mL kg-1. As is true for assumption 13 (Sect. 2.5.2), as-
sumption 15 is an approximation.
4.4.3 Transbrachial dZ/dtmax is an ohmic analog of peak
brachial artery acceleration
Transthoracically, the assumption that dZ/dtmax peaks
synchronously with the I wave of the acceleration ballis-
tocardiogram (aBCG) [21, 30], in the time-domain, has
recently been challenged. Luchitskaya et al. and Ulbrich
et al. have shown experimentally that, dZ/dtmax peaks
*23–28 ms after peak acceleration of blood flow [36, 37],
but before peak aortic blood flow (dV/dtmax). This finding
would appear to somewhat question the acceleratory nature
of transthoracic dZ/dtmax and necessity for the square root
acceleration step-down transformation to obtain ohmic
mean velocity (Sect. 2.5.2 assumptions 7–12).
Operationally, however, when implementing the transtho-
racic technique, the parent equation of Eq. 2 has been
validated extensively according to assumption 12 (Sect.
2.5.2) [38–43]. Experimentally, it has been definitively
demonstrated that an equation using square root transfor-
mation of dZ/dtmax/Z0 provides better agreement and cor-
relation with TDCO than equations which assume a
volumetric origin for dZ/dtmax [30]. Despite the findings
disputing the peak acceleratory origin of transthoracic dZ/
dtmax [36, 37], pictorial and analytical evidence provided
by Bernstein [21] clearly indicates that dZ/dtmax peaks
synchronously with peak aortic blood acceleration and I
wave of the aBCG. Thus, although transthoracic dZ/dtmax
may not peak precisely with peak acceleration, but closely
within the time domain, it can be treated as such. More-
over, with respect to the transbrachial method, it has been
definitively demonstrated that peak Doppler brachial artery
blood acceleration and peak brachial artery ohmic accel-
eration reach their magnitudes synchronously in the time
domain [15, figure 8c, d]. This appears to validate as-
sumption 7 (Sect. 2.5.2).
It should be fully appreciated that the TBEV technique
may not provide credible SV or CO values in the presence
of critical illness. However, this and our previous study
[15], both showing proof of concept, serve as evidence that
SV can be obtained by TBEV technique in the ideal
homeostatic hemodynamic state. Future validation studies
in sick humans, comparing TBEV to another validated
continuous SV/CO technique, such as in the studies by
Metzelder et al. [35] and Lorne et al. [44], will determine
the viability of TBEV in clinical medicine.
5 Conclusion
In this study, we present a comparison of SV and CO ob-
tained via electrical interrogation of the brachial artery by
the TBEV technique with SV and CO obtained by cMRI in
normals. Despite its potential sources of error, we found that
TBEV resulted in satisfactory reproducibility and agreement
with cMRI. While not interchangeable with cMRI, based on
existing criteria for the reproducibility of pulmonary artery
TDCO [45, 46] and its LOA, [46] the precision and accuracy
of TBEV CO obtained in this study may be clinically ac-
ceptable if maintained in the critically ill.
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